New treatment for Ecstasy-related hyperthermia.
Blessing
W W
WW
Departments of Physiology and Medicine, Centre for Neuroscience, Flinders University Medical Centre, Bedford Park, Adelaide, SA 5042, Australia. w.w.blessing@flinders.edu.au
D000818:Animals; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use*; D003024:Clozapine / Q000627:therapeutic use*; D004195:Disease Models, Animal; D005334:Fever / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D000077152:Olanzapine; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D012702:Serotonin Antagonists; D001569:Benzodiazepines; D003024:Clozapine; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D000077152:Olanzapine